• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心脏病病理生理学范式概述:从斑块激活到微血管功能障碍。

Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction.

机构信息

Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, Italy.

Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.

出版信息

Int J Mol Sci. 2020 Oct 30;21(21):8118. doi: 10.3390/ijms21218118.

DOI:10.3390/ijms21218118
PMID:33143256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7663258/
Abstract

Ischemic heart disease still represents a large burden on individuals and health care resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow-limiting obstruction in large-medium sized coronary arteries. However, clinical, angiographic and autoptic findings suggest a multifaceted pathophysiology for ischemic heart disease and just some cases are caused by severe or complicated atherosclerotic plaques. Currently there is no well-defined assessment of ischemic heart disease pathophysiology that satisfies all the observations and sometimes the underlying mechanism to everyday ischemic heart disease ward cases is misleading. In order to better examine this complicated disease and to provide future perspectives, it is important to know and analyze the pathophysiological mechanisms that underline it, because ischemic heart disease is not always determined by atherosclerotic plaque complication. Therefore, in order to have a more complete comprehension of ischemic heart disease we propose an overview of the available pathophysiological paradigms, from plaque activation to microvascular dysfunction.

摘要

缺血性心脏病仍然是全球个人和医疗保健资源的沉重负担。根据惯例,它等同于由于大-中型冠状动脉中的血流限制阻塞导致的动脉粥样硬化斑块。然而,临床、血管造影和尸检结果表明,缺血性心脏病存在多方面的病理生理学,只有一些病例是由严重或复杂的动脉粥样硬化斑块引起的。目前,还没有一种能够满足所有观察结果的、明确的缺血性心脏病病理生理学评估方法,有时导致日常缺血性心脏病病房病例的潜在机制存在误导性。为了更好地研究这种复杂的疾病并提供未来的展望,了解和分析其潜在的病理生理学机制非常重要,因为缺血性心脏病并不总是由动脉粥样硬化斑块并发症决定的。因此,为了更全面地理解缺血性心脏病,我们提出了一个概述,介绍了从斑块激活到微血管功能障碍的可用病理生理学范例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391f/7663258/4cd7c7f967c3/ijms-21-08118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391f/7663258/704026a8eaae/ijms-21-08118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391f/7663258/4cd7c7f967c3/ijms-21-08118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391f/7663258/704026a8eaae/ijms-21-08118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391f/7663258/4cd7c7f967c3/ijms-21-08118-g002.jpg

相似文献

1
Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction.缺血性心脏病病理生理学范式概述:从斑块激活到微血管功能障碍。
Int J Mol Sci. 2020 Oct 30;21(21):8118. doi: 10.3390/ijms21218118.
2
Beyond Coronary Artery Disease: Assessing the Microcirculation.超越冠状动脉疾病:评估微循环。
Rheum Dis Clin North Am. 2024 Aug;50(3):519-533. doi: 10.1016/j.rdc.2024.03.004.
3
How to study coronary microvascular dysfunction and its clinical relevance.如何研究冠状动脉微血管功能障碍及其临床意义。
Ital Heart J. 2002 Apr;3(4):230-6.
4
Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels.缺血性心脏病和心力衰竭:冠状动脉离子通道的作用。
Int J Mol Sci. 2020 Apr 30;21(9):3167. doi: 10.3390/ijms21093167.
5
Role of local coronary blood flow patterns and shear stress on the development of microvascular and epicardial endothelial dysfunction and coronary plaque.局部冠状动脉血流模式和切应力对微血管和心外膜内皮功能障碍及冠状动脉斑块形成的作用。
Curr Opin Cardiol. 2018 Nov;33(6):638-644. doi: 10.1097/HCO.0000000000000571.
6
Pathophysiology of Atherosclerotic Plaque Development.动脉粥样硬化斑块形成的病理生理学
Cardiovasc Hematol Agents Med Chem. 2015;13(1):10-3. doi: 10.2174/1871525713666141218163425.
7
Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease.用血流储备分数评估的伴有中度狭窄病变的冠状动脉血流动力学紊乱:缺血性心脏病中心外膜和微循环受累的联合分析。
Circulation. 2013 Dec 17;128(24):2557-66. doi: 10.1161/CIRCULATIONAHA.112.001345. Epub 2013 Oct 18.
8
Sex Differences in the Coronary System.冠状动脉系统的性别差异。
Adv Exp Med Biol. 2018;1065:257-278. doi: 10.1007/978-3-319-77932-4_17.
9
Coronary Microvascular Dysfunction Is Associated With Significant Plaque Burden and Diffuse Epicardial Atherosclerotic Disease.冠状动脉微血管功能障碍与显著的斑块负荷及弥漫性心外膜动脉粥样硬化疾病相关。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1519-1520. doi: 10.1016/j.jcin.2019.05.003.
10
Reappraisal of Ischemic Heart Disease.缺血性心脏病再评估。
Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373.

引用本文的文献

1
Assessment of Microvascular Function in Angina Pectoris by Angiography-Based Index of Microcirculation Resistance: A Meta-Analysis.基于血管造影术的微循环阻力指数评估心绞痛患者的微血管功能:一项荟萃分析
Rev Cardiovasc Med. 2025 Aug 25;26(8):25764. doi: 10.31083/RCM25764. eCollection 2025 Aug.
2
Global, regional, and national burden of ischemic heart disease attributable to lead exposure, 1990-2021: decomposition, frontier, and projection analysis.1990 - 2021年全球、区域和国家因铅暴露导致的缺血性心脏病负担:分解、前沿和预测分析
Front Public Health. 2025 Aug 18;13:1567747. doi: 10.3389/fpubh.2025.1567747. eCollection 2025.
3

本文引用的文献

1
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Rev Esp Cardiol (Engl Ed). 2021 Jun;74(6):544. doi: 10.1016/j.rec.2021.05.002.
2
Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors.缺血性心脏病易感性:聚焦于传统危险因素之外的ATP敏感性钾通道基因变异
Eur J Prev Cardiol. 2021 Oct 25;28(13):1495-1500. doi: 10.1177/2047487320926780.
3
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak.
The Role of Myocardial Revascularization in Ischemic Heart Failure in the Era of Modern Optimal Medical Therapy.
现代最佳药物治疗时代心肌血运重建在缺血性心力衰竭中的作用
Medicina (Kaunas). 2025 Aug 12;61(8):1451. doi: 10.3390/medicina61081451.
4
Sanguinarine attenuates hypoxia/reoxygenation-triggered H9c2 cell injury through activation of the Nrf2/NLRP3 pathway.血根碱通过激活Nrf2/NLRP3信号通路减轻缺氧/复氧诱导的H9c2细胞损伤。
J Clin Biochem Nutr. 2025 Jul;77(1):37-44. doi: 10.3164/jcbn.24-235. Epub 2025 Apr 11.
5
LC-MS Analysis of the Polyphenolic Composition and Assessment of the Antioxidant, Anti-Inflammatory and Cardioprotective Activities of and Extracts.对[具体提取物名称1]和[具体提取物名称2]提取物的多酚成分进行液相色谱-质谱联用分析,并评估其抗氧化、抗炎和心脏保护活性。
Plants (Basel). 2025 Jul 9;14(14):2122. doi: 10.3390/plants14142122.
6
Contributions of Pathobiological and Translational Science to Understanding and Managing Ischemic Heart Disease: Progress, Impediments, and Future Directions.病理生物学与转化科学在理解和管理缺血性心脏病方面的贡献:进展、障碍与未来方向
Tex Heart Inst J. 2025 Jul 21;52(2):e258609. doi: 10.145403/THIJ-25-8609. eCollection 2025 Jul-Dec.
7
Integrative genetic analysis of shared genetic architecture of stroke and coronary artery disease: implications for pharmacist-led precision medicine.中风与冠状动脉疾病共享遗传结构的综合遗传分析:对药剂师主导的精准医学的启示。
Int J Clin Pharm. 2025 Jun 30. doi: 10.1007/s11096-025-01952-w.
8
Human CD36: Gene Regulation, Protein Function, and Its Role in Atherosclerosis Pathogenesis.人类CD36:基因调控、蛋白质功能及其在动脉粥样硬化发病机制中的作用。
Genes (Basel). 2025 Jun 13;16(6):705. doi: 10.3390/genes16060705.
9
Research progress on molecular mechanism and future perspectives of leonurine.益母草碱的分子机制研究进展及未来展望
Front Med. 2025 Jun 20. doi: 10.1007/s11684-025-1138-2.
10
Risk stratification study of non-calcified coronary plaques based on CT pericoronary adipose tissue measurement.基于CT测量冠状动脉周围脂肪组织的非钙化冠状动脉斑块风险分层研究
Int J Cardiovasc Imaging. 2025 May 16. doi: 10.1007/s10554-025-03425-7.
新型冠状病毒肺炎大流行期间心力衰竭住院率的降低
ESC Heart Fail. 2020 Dec;7(6):4182-4188. doi: 10.1002/ehf2.13043. Epub 2020 Oct 23.
4
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis.直接口服抗凝剂与维生素 K 拮抗剂在伴有房颤和癌症患者中的应用:一项荟萃分析。
J Thromb Thrombolysis. 2021 Feb;51(2):419-429. doi: 10.1007/s11239-020-02304-3. Epub 2020 Oct 12.
5
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: Lessons learned during Italian lockdown.COVID-19 大流行期间心脏植入式电子设备随访的管理:意大利封锁期间的经验教训。
J Cardiovasc Electrophysiol. 2020 Nov;31(11):2814-2823. doi: 10.1111/jce.14755. Epub 2020 Sep 30.
6
Coronavirus disease 2019 in Rome: was it circulating before December?罗马的2019冠状病毒病:12月之前它就在传播了吗?
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):835-836. doi: 10.2459/JCM.0000000000001089.
7
The role of cardiologists in the coronavirus disease 2019 pandemic.心脏病专家在2019年冠状病毒病大流行中的作用。
Kardiol Pol. 2020 Aug 25;78(7-8):808-809. doi: 10.33963/KP.15572.
8
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.新型冠状病毒肺炎中的血管内皮功能障碍:欧洲心脏病学会动脉粥样硬化和血管生物学工作组以及欧洲心脏病学会心血管基础科学理事会立场文件。
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184. doi: 10.1093/cvr/cvaa230.
9
Left ventricular wall stress is associated with myocardial functional recovery in patients with severe aortic stenosis and systolic dysfunction undergoing transcatheter aortic valve replacement.对于重度主动脉瓣狭窄合并收缩功能障碍且正在接受经导管主动脉瓣置换术的患者,左心室壁应力与心肌功能恢复相关。
J Cardiovasc Med (Hagerstown). 2021 Jan;22(1):66-68. doi: 10.2459/JCM.0000000000001069.
10
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.